1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmology Drugs & Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Ophthalmology Drugs & Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Ophthalmology Drugs & Devices by Country/Region, 2018, 2022 & 2029
2.2 Ophthalmology Drugs & Devices Segment by Type
2.2.1 Diagnostic and Monitoring Devices
2.2.2 Surgical Devices
2.2.3 Vision Care Product
2.2.4 Ophthalmology Drugs
2.3 Ophthalmology Drugs & Devices Sales by Type
2.3.1 Global Ophthalmology Drugs & Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Ophthalmology Drugs & Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Ophthalmology Drugs & Devices Sale Price by Type (2018-2023)
2.4 Ophthalmology Drugs & Devices Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Ambulatory Surgical Centers (ASCs)
2.5 Ophthalmology Drugs & Devices Sales by Application
2.5.1 Global Ophthalmology Drugs & Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Ophthalmology Drugs & Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Ophthalmology Drugs & Devices Sale Price by Application (2018-2023)
3 Global Ophthalmology Drugs & Devices by Company
3.1 Global Ophthalmology Drugs & Devices Breakdown Data by Company
3.1.1 Global Ophthalmology Drugs & Devices Annual Sales by Company (2018-2023)
3.1.2 Global Ophthalmology Drugs & Devices Sales Market Share by Company (2018-2023)
3.2 Global Ophthalmology Drugs & Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Ophthalmology Drugs & Devices Revenue by Company (2018-2023)
3.2.2 Global Ophthalmology Drugs & Devices Revenue Market Share by Company (2018-2023)
3.3 Global Ophthalmology Drugs & Devices Sale Price by Company
3.4 Key Manufacturers Ophthalmology Drugs & Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmology Drugs & Devices Product Location Distribution
3.4.2 Players Ophthalmology Drugs & Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ophthalmology Drugs & Devices by Geographic Region
4.1 World Historic Ophthalmology Drugs & Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Ophthalmology Drugs & Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Ophthalmology Drugs & Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ophthalmology Drugs & Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Ophthalmology Drugs & Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Ophthalmology Drugs & Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ophthalmology Drugs & Devices Sales Growth
4.4 APAC Ophthalmology Drugs & Devices Sales Growth
4.5 Europe Ophthalmology Drugs & Devices Sales Growth
4.6 Middle East & Africa Ophthalmology Drugs & Devices Sales Growth
5 Americas
5.1 Americas Ophthalmology Drugs & Devices Sales by Country
5.1.1 Americas Ophthalmology Drugs & Devices Sales by Country (2018-2023)
5.1.2 Americas Ophthalmology Drugs & Devices Revenue by Country (2018-2023)
5.2 Americas Ophthalmology Drugs & Devices Sales by Type
5.3 Americas Ophthalmology Drugs & Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmology Drugs & Devices Sales by Region
6.1.1 APAC Ophthalmology Drugs & Devices Sales by Region (2018-2023)
6.1.2 APAC Ophthalmology Drugs & Devices Revenue by Region (2018-2023)
6.2 APAC Ophthalmology Drugs & Devices Sales by Type
6.3 APAC Ophthalmology Drugs & Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ophthalmology Drugs & Devices by Country
7.1.1 Europe Ophthalmology Drugs & Devices Sales by Country (2018-2023)
7.1.2 Europe Ophthalmology Drugs & Devices Revenue by Country (2018-2023)
7.2 Europe Ophthalmology Drugs & Devices Sales by Type
7.3 Europe Ophthalmology Drugs & Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmology Drugs & Devices by Country
8.1.1 Middle East & Africa Ophthalmology Drugs & Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Ophthalmology Drugs & Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Ophthalmology Drugs & Devices Sales by Type
8.3 Middle East & Africa Ophthalmology Drugs & Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmology Drugs & Devices
10.3 Manufacturing Process Analysis of Ophthalmology Drugs & Devices
10.4 Industry Chain Structure of Ophthalmology Drugs & Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmology Drugs & Devices Distributors
11.3 Ophthalmology Drugs & Devices Customer
12 World Forecast Review for Ophthalmology Drugs & Devices by Geographic Region
12.1 Global Ophthalmology Drugs & Devices Market Size Forecast by Region
12.1.1 Global Ophthalmology Drugs & Devices Forecast by Region (2024-2029)
12.1.2 Global Ophthalmology Drugs & Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmology Drugs & Devices Forecast by Type
12.7 Global Ophthalmology Drugs & Devices Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.1.3 Abbott Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Alcon
13.2.1 Alcon Company Information
13.2.2 Alcon Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.2.3 Alcon Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Alcon Main Business Overview
13.2.5 Alcon Latest Developments
13.3 Allergan
13.3.1 Allergan Company Information
13.3.2 Allergan Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.3.3 Allergan Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Allergan Main Business Overview
13.3.5 Allergan Latest Developments
13.4 Bausch & Lomb
13.4.1 Bausch & Lomb Company Information
13.4.2 Bausch & Lomb Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.4.3 Bausch & Lomb Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bausch & Lomb Main Business Overview
13.4.5 Bausch & Lomb Latest Developments
13.5 Carl Zeiss Meditec
13.5.1 Carl Zeiss Meditec Company Information
13.5.2 Carl Zeiss Meditec Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.5.3 Carl Zeiss Meditec Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Carl Zeiss Meditec Main Business Overview
13.5.5 Carl Zeiss Meditec Latest Developments
13.6 Ellex
13.6.1 Ellex Company Information
13.6.2 Ellex Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.6.3 Ellex Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ellex Main Business Overview
13.6.5 Ellex Latest Developments
13.7 Essilor
13.7.1 Essilor Company Information
13.7.2 Essilor Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.7.3 Essilor Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Essilor Main Business Overview
13.7.5 Essilor Latest Developments
13.8 Hoya
13.8.1 Hoya Company Information
13.8.2 Hoya Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.8.3 Hoya Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hoya Main Business Overview
13.8.5 Hoya Latest Developments
13.9 Iridex
13.9.1 Iridex Company Information
13.9.2 Iridex Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.9.3 Iridex Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Iridex Main Business Overview
13.9.5 Iridex Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.10.3 Johnson & Johnson Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
13.11 Merck & Co.
13.11.1 Merck & Co. Company Information
13.11.2 Merck & Co. Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.11.3 Merck & Co. Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Merck & Co. Main Business Overview
13.11.5 Merck & Co. Latest Developments
13.12 Nidek Co.
13.12.1 Nidek Co. Company Information
13.12.2 Nidek Co. Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.12.3 Nidek Co. Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nidek Co. Main Business Overview
13.12.5 Nidek Co. Latest Developments
13.13 Santen Pharmaceutical
13.13.1 Santen Pharmaceutical Company Information
13.13.2 Santen Pharmaceutical Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.13.3 Santen Pharmaceutical Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Santen Pharmaceutical Main Business Overview
13.13.5 Santen Pharmaceutical Latest Developments
13.14 Novartis
13.14.1 Novartis Company Information
13.14.2 Novartis Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.14.3 Novartis Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Novartis Main Business Overview
13.14.5 Novartis Latest Developments
13.15 Pfizer
13.15.1 Pfizer Company Information
13.15.2 Pfizer Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.15.3 Pfizer Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Pfizer Main Business Overview
13.15.5 Pfizer Latest Developments
13.16 Roche Holding
13.16.1 Roche Holding Company Information
13.16.2 Roche Holding Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.16.3 Roche Holding Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Roche Holding Main Business Overview
13.16.5 Roche Holding Latest Developments
13.17 Staar Surgical
13.17.1 Staar Surgical Company Information
13.17.2 Staar Surgical Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.17.3 Staar Surgical Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Staar Surgical Main Business Overview
13.17.5 Staar Surgical Latest Developments
13.18 Topcon
13.18.1 Topcon Company Information
13.18.2 Topcon Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.18.3 Topcon Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Topcon Main Business Overview
13.18.5 Topcon Latest Developments
13.19 Ziemer Ophthalmic Systems
13.19.1 Ziemer Ophthalmic Systems Company Information
13.19.2 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Product Portfolios and Specifications
13.19.3 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Ziemer Ophthalmic Systems Main Business Overview
13.19.5 Ziemer Ophthalmic Systems Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Ophthalmology Drugs & Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Ophthalmology Drugs & Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Diagnostic and Monitoring Devices
Table 4. Major Players of Surgical Devices
Table 5. Major Players of Vision Care Product
Table 6. Major Players of Ophthalmology Drugs
Table 7. Global Ophthalmology Drugs & Devices Sales by Type (2018-2023) & (K Units)
Table 8. Global Ophthalmology Drugs & Devices Sales Market Share by Type (2018-2023)
Table 9. Global Ophthalmology Drugs & Devices Revenue by Type (2018-2023) & ($ million)
Table 10. Global Ophthalmology Drugs & Devices Revenue Market Share by Type (2018-2023)
Table 11. Global Ophthalmology Drugs & Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Ophthalmology Drugs & Devices Sales by Application (2018-2023) & (K Units)
Table 13. Global Ophthalmology Drugs & Devices Sales Market Share by Application (2018-2023)
Table 14. Global Ophthalmology Drugs & Devices Revenue by Application (2018-2023)
Table 15. Global Ophthalmology Drugs & Devices Revenue Market Share by Application (2018-2023)
Table 16. Global Ophthalmology Drugs & Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Ophthalmology Drugs & Devices Sales by Company (2018-2023) & (K Units)
Table 18. Global Ophthalmology Drugs & Devices Sales Market Share by Company (2018-2023)
Table 19. Global Ophthalmology Drugs & Devices Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Ophthalmology Drugs & Devices Revenue Market Share by Company (2018-2023)
Table 21. Global Ophthalmology Drugs & Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Ophthalmology Drugs & Devices Producing Area Distribution and Sales Area
Table 23. Players Ophthalmology Drugs & Devices Products Offered
Table 24. Ophthalmology Drugs & Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Ophthalmology Drugs & Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Ophthalmology Drugs & Devices Sales Market Share Geographic Region (2018-2023)
Table 29. Global Ophthalmology Drugs & Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Ophthalmology Drugs & Devices Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Ophthalmology Drugs & Devices Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Ophthalmology Drugs & Devices Sales Market Share by Country/Region (2018-2023)
Table 33. Global Ophthalmology Drugs & Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Ophthalmology Drugs & Devices Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Ophthalmology Drugs & Devices Sales by Country (2018-2023) & (K Units)
Table 36. Americas Ophthalmology Drugs & Devices Sales Market Share by Country (2018-2023)
Table 37. Americas Ophthalmology Drugs & Devices Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Ophthalmology Drugs & Devices Revenue Market Share by Country (2018-2023)
Table 39. Americas Ophthalmology Drugs & Devices Sales by Type (2018-2023) & (K Units)
Table 40. Americas Ophthalmology Drugs & Devices Sales by Application (2018-2023) & (K Units)
Table 41. APAC Ophthalmology Drugs & Devices Sales by Region (2018-2023) & (K Units)
Table 42. APAC Ophthalmology Drugs & Devices Sales Market Share by Region (2018-2023)
Table 43. APAC Ophthalmology Drugs & Devices Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Ophthalmology Drugs & Devices Revenue Market Share by Region (2018-2023)
Table 45. APAC Ophthalmology Drugs & Devices Sales by Type (2018-2023) & (K Units)
Table 46. APAC Ophthalmology Drugs & Devices Sales by Application (2018-2023) & (K Units)
Table 47. Europe Ophthalmology Drugs & Devices Sales by Country (2018-2023) & (K Units)
Table 48. Europe Ophthalmology Drugs & Devices Sales Market Share by Country (2018-2023)
Table 49. Europe Ophthalmology Drugs & Devices Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Ophthalmology Drugs & Devices Revenue Market Share by Country (2018-2023)
Table 51. Europe Ophthalmology Drugs & Devices Sales by Type (2018-2023) & (K Units)
Table 52. Europe Ophthalmology Drugs & Devices Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Ophthalmology Drugs & Devices Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Ophthalmology Drugs & Devices Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Ophthalmology Drugs & Devices Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Ophthalmology Drugs & Devices Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Ophthalmology Drugs & Devices Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Ophthalmology Drugs & Devices Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Ophthalmology Drugs & Devices
Table 60. Key Market Challenges & Risks of Ophthalmology Drugs & Devices
Table 61. Key Industry Trends of Ophthalmology Drugs & Devices
Table 62. Ophthalmology Drugs & Devices Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Ophthalmology Drugs & Devices Distributors List
Table 65. Ophthalmology Drugs & Devices Customer List
Table 66. Global Ophthalmology Drugs & Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Ophthalmology Drugs & Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Ophthalmology Drugs & Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Ophthalmology Drugs & Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Ophthalmology Drugs & Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Ophthalmology Drugs & Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Ophthalmology Drugs & Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Ophthalmology Drugs & Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Ophthalmology Drugs & Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Ophthalmology Drugs & Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Ophthalmology Drugs & Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Ophthalmology Drugs & Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Ophthalmology Drugs & Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Ophthalmology Drugs & Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Abbott Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 81. Abbott Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 82. Abbott Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Main Business
Table 84. Abbott Latest Developments
Table 85. Alcon Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 86. Alcon Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 87. Alcon Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Alcon Main Business
Table 89. Alcon Latest Developments
Table 90. Allergan Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 91. Allergan Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 92. Allergan Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Allergan Main Business
Table 94. Allergan Latest Developments
Table 95. Bausch & Lomb Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 96. Bausch & Lomb Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 97. Bausch & Lomb Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Bausch & Lomb Main Business
Table 99. Bausch & Lomb Latest Developments
Table 100. Carl Zeiss Meditec Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 101. Carl Zeiss Meditec Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 102. Carl Zeiss Meditec Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Carl Zeiss Meditec Main Business
Table 104. Carl Zeiss Meditec Latest Developments
Table 105. Ellex Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. Ellex Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 107. Ellex Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Ellex Main Business
Table 109. Ellex Latest Developments
Table 110. Essilor Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 111. Essilor Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 112. Essilor Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Essilor Main Business
Table 114. Essilor Latest Developments
Table 115. Hoya Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 116. Hoya Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 117. Hoya Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Hoya Main Business
Table 119. Hoya Latest Developments
Table 120. Iridex Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 121. Iridex Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 122. Iridex Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Iridex Main Business
Table 124. Iridex Latest Developments
Table 125. Johnson & Johnson Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 126. Johnson & Johnson Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 127. Johnson & Johnson Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Johnson & Johnson Main Business
Table 129. Johnson & Johnson Latest Developments
Table 130. Merck & Co. Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 131. Merck & Co. Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 132. Merck & Co. Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Merck & Co. Main Business
Table 134. Merck & Co. Latest Developments
Table 135. Nidek Co. Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 136. Nidek Co. Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 137. Nidek Co. Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Nidek Co. Main Business
Table 139. Nidek Co. Latest Developments
Table 140. Santen Pharmaceutical Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 141. Santen Pharmaceutical Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 142. Santen Pharmaceutical Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Santen Pharmaceutical Main Business
Table 144. Santen Pharmaceutical Latest Developments
Table 145. Novartis Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 146. Novartis Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 147. Novartis Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Novartis Main Business
Table 149. Novartis Latest Developments
Table 150. Pfizer Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 151. Pfizer Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 152. Pfizer Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Pfizer Main Business
Table 154. Pfizer Latest Developments
Table 155. Roche Holding Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 156. Roche Holding Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 157. Roche Holding Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Roche Holding Main Business
Table 159. Roche Holding Latest Developments
Table 160. Staar Surgical Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 161. Staar Surgical Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 162. Staar Surgical Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Staar Surgical Main Business
Table 164. Staar Surgical Latest Developments
Table 165. Topcon Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 166. Topcon Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 167. Topcon Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. Topcon Main Business
Table 169. Topcon Latest Developments
Table 170. Ziemer Ophthalmic Systems Basic Information, Ophthalmology Drugs & Devices Manufacturing Base, Sales Area and Its Competitors
Table 171. Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Product Portfolios and Specifications
Table 172. Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 173. Ziemer Ophthalmic Systems Main Business
Table 174. Ziemer Ophthalmic Systems Latest Developments
List of Figures
Figure 1. Picture of Ophthalmology Drugs & Devices
Figure 2. Ophthalmology Drugs & Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmology Drugs & Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Ophthalmology Drugs & Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Ophthalmology Drugs & Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Diagnostic and Monitoring Devices
Figure 10. Product Picture of Surgical Devices
Figure 11. Product Picture of Vision Care Product
Figure 12. Product Picture of Ophthalmology Drugs
Figure 13. Global Ophthalmology Drugs & Devices Sales Market Share by Type in 2022
Figure 14. Global Ophthalmology Drugs & Devices Revenue Market Share by Type (2018-2023)
Figure 15. Ophthalmology Drugs & Devices Consumed in Hospitals
Figure 16. Global Ophthalmology Drugs & Devices Market: Hospitals (2018-2023) & (K Units)
Figure 17. Ophthalmology Drugs & Devices Consumed in Specialty Clinics
Figure 18. Global Ophthalmology Drugs & Devices Market: Specialty Clinics (2018-2023) & (K Units)
Figure 19. Ophthalmology Drugs & Devices Consumed in Ambulatory Surgical Centers (ASCs)
Figure 20. Global Ophthalmology Drugs & Devices Market: Ambulatory Surgical Centers (ASCs) (2018-2023) & (K Units)
Figure 21. Global Ophthalmology Drugs & Devices Sales Market Share by Application (2022)
Figure 22. Global Ophthalmology Drugs & Devices Revenue Market Share by Application in 2022
Figure 23. Ophthalmology Drugs & Devices Sales Market by Company in 2022 (K Units)
Figure 24. Global Ophthalmology Drugs & Devices Sales Market Share by Company in 2022
Figure 25. Ophthalmology Drugs & Devices Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Ophthalmology Drugs & Devices Revenue Market Share by Company in 2022
Figure 27. Global Ophthalmology Drugs & Devices Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Ophthalmology Drugs & Devices Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Ophthalmology Drugs & Devices Sales 2018-2023 (K Units)
Figure 30. Americas Ophthalmology Drugs & Devices Revenue 2018-2023 ($ Millions)
Figure 31. APAC Ophthalmology Drugs & Devices Sales 2018-2023 (K Units)
Figure 32. APAC Ophthalmology Drugs & Devices Revenue 2018-2023 ($ Millions)
Figure 33. Europe Ophthalmology Drugs & Devices Sales 2018-2023 (K Units)
Figure 34. Europe Ophthalmology Drugs & Devices Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Ophthalmology Drugs & Devices Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Ophthalmology Drugs & Devices Revenue 2018-2023 ($ Millions)
Figure 37. Americas Ophthalmology Drugs & Devices Sales Market Share by Country in 2022
Figure 38. Americas Ophthalmology Drugs & Devices Revenue Market Share by Country in 2022
Figure 39. Americas Ophthalmology Drugs & Devices Sales Market Share by Type (2018-2023)
Figure 40. Americas Ophthalmology Drugs & Devices Sales Market Share by Application (2018-2023)
Figure 41. United States Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Ophthalmology Drugs & Devices Sales Market Share by Region in 2022
Figure 46. APAC Ophthalmology Drugs & Devices Revenue Market Share by Regions in 2022
Figure 47. APAC Ophthalmology Drugs & Devices Sales Market Share by Type (2018-2023)
Figure 48. APAC Ophthalmology Drugs & Devices Sales Market Share by Application (2018-2023)
Figure 49. China Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Ophthalmology Drugs & Devices Sales Market Share by Country in 2022
Figure 57. Europe Ophthalmology Drugs & Devices Revenue Market Share by Country in 2022
Figure 58. Europe Ophthalmology Drugs & Devices Sales Market Share by Type (2018-2023)
Figure 59. Europe Ophthalmology Drugs & Devices Sales Market Share by Application (2018-2023)
Figure 60. Germany Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Ophthalmology Drugs & Devices Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Ophthalmology Drugs & Devices Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Ophthalmology Drugs & Devices Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Ophthalmology Drugs & Devices Sales Market Share by Application (2018-2023)
Figure 69. Egypt Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Ophthalmology Drugs & Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Ophthalmology Drugs & Devices in 2022
Figure 75. Manufacturing Process Analysis of Ophthalmology Drugs & Devices
Figure 76. Industry Chain Structure of Ophthalmology Drugs & Devices
Figure 77. Channels of Distribution
Figure 78. Global Ophthalmology Drugs & Devices Sales Market Forecast by Region (2024-2029)
Figure 79. Global Ophthalmology Drugs & Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Ophthalmology Drugs & Devices Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Ophthalmology Drugs & Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Ophthalmology Drugs & Devices Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Ophthalmology Drugs & Devices Revenue Market Share Forecast by Application (2024-2029)

※参考情報 眼科用医薬品と機器は、目の健康を保つために必要不可欠なアイテムであり、多くの患者にとって視力の維持や改善、さらには眼疾患の治療に重要な役割を果たしています。眼科は非常に専門的な分野であり、視覚器官に関連するさまざまな疾患や障害を診断・治療するための医薬品や機器の開発が進められています。 まず、眼科用医薬品とは、目の疾病や異常を治療・予防・管理するための薬剤を指します。これには抗炎症薬、抗菌薬、抗ウイルス薬、抗アレルギー薬、緑内障治療薬、視力補助薬などが含まれます。これらの医薬品は、点眼剤として使用されることが一般的で、目の表面や内部に直接作用するため、効果的に数多くの眼疾患に対処することができます。 例えば、抗炎症薬は角膜炎やぶどう膜炎といった炎症性疾患に用いられます。これらの薬剤は、炎症を抑えることで症状を軽減し、回復を促進します。抗菌薬は細菌感染を引き起こすことがある眼の疾患に対して使用され、感染を抑える役割を果たします。さらに、抗ウイルス薬は、ヘルペスウイルスによる眼感染症などに対して処方されることがあります。 緑内障治療薬は特に重要であり、眼圧を低下させることで視神経の損傷を防ぎます。これには、β遮断薬、プロスタグランジン類似物質、炭酸脱水酵素阻害薬などが含まれ、患者の状態や反応に応じて選択されます。 次に、眼科用機器について考えてみましょう。眼科における診断や治療に利用される機器は多岐にわたります。まず、視力検査に使用される視力表やオクルーダー、視野計などがあります。視力検査は、眼科診療の基本であり、さまざまな疾患の発見や進行具合の測定に用いられます。視野計は、視野の欠損や障害を評価するための重要なツールです。 また、網膜や眼底を詳しく観察するための機器も数多く存在します。眼底カメラやOCT（光干渉断層計）は、網膜の詳細な画像を取得することができ、疾患の早期発見に大きく寄与しています。OCTは特に、網膜の層構造を可視化することができ、黄斑疾患や糖尿病網膜症の診断において重要です。 手術用機器も眼科には欠かせません。白内障手術に使用されるファコエムルシフィケーション装置や、緑内障治療のためのトラベクレクトミーを行う際に使用される手術器具などがあります。近年では、レーザー技術が進化し、各種眼科手術に幅広く利用されています。レーザー治療は、高精度で低侵襲な治療法を提供可能で、患者の回復を早めることができます。 さらに、関連技術の進展についても触れておきましょう。テクノロジーの進化により、眼科診療は大きく変化しています。遠隔医療の導入により、患者が自宅からでも眼科医による診察を受けることが可能になっています。また、人工知能を用いた診断システムが開発されており、画像解析によって疾患の早期発見をサポートする技術が確立されてきています。 これらの進展により、眼科はより専門的な治療が提供できるようになり、患者の負担を軽減しつつ、質の高い医療を実現する方向に進んでいます。このように、眼科用医薬品と機器は、視覚の健康を維持・向上させるために重要な役割を果たし続けています。視力は日常生活において非常に重要な要素であり、眼科の診療と技術の進歩により、多くの人々が快適に暮らせる社会の実現が期待されています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer